Literature DB >> 8303905

The changing pattern of cardiovascular diseases in China.

C Yao1, Z Wu, Y Wu.   

Abstract

In China, morbidity and mortality attributable to cardiovascular disease increased rapidly from the 1950s to the 1980s due to an increased life expectancy and changes in lifestyle. Cardiovascular disease has become the leading cause of death in the country. There is a high incidence of stroke, which is the commonest or second commonest cause of death. Hypertension, the main risk factor for stroke and an important risk factor for coronary heart disease, is the most prevalent cardiovascular disease, and should be given first priority in control programmes. Smoking, a common habit in males, is to be a principal focus of preventive activities over the next few years. Between 1970 and 1990, several community programmes for the prevention and control of cardiovascular diseases were established. The WHO MONICA Project has developed standardized methodologies that are used to establish systems for monitoring and evaluating control programmes. There is an urgent need to develop a long-term national strategy for the management and control of cardiovascular diseases.

Entities:  

Keywords:  Asia; Behavior; Biology; Cardiovascular Effects--determinants; Causes Of Death; China; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Eastern Asia; Health; Health Services; Hypertension; Medicine; Morbidity; Mortality; Physiology; Population; Population Dynamics; Preventive Medicine; Risk Factors; Smoking; Vascular Diseases

Mesh:

Substances:

Year:  1993        PMID: 8303905

Source DB:  PubMed          Journal:  World Health Stat Q        ISSN: 0379-8070


  11 in total

Review 1.  Novel serologic markers of cardiovascular risk.

Authors:  Guilherme H M Oliveira
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

Review 2.  Primordial prevention, developing countries and the epidemiological transition: thirty years later.

Authors:  Sorin Ursoniu
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

3.  Perceptions of risk factors of cardiovascular disease and cardiac rehabilitation: a cross-sectional study targeting the Chinese population in the Midlands, UK.

Authors:  Tay Za; Jeff C F Lau; Arthur C K Wong; Alice W S Wong; Sally Lui; James W D Fong; Patrick Y C Chow; Kate B Jolly
Journal:  Heart Asia       Date:  2012-01-01

Review 4.  Hypertension in the developing world: a consequence of progress.

Authors:  K Srinath Reddy; Nitish Naik; Dorairaj Prabhakaran
Journal:  Curr Cardiol Rep       Date:  2006-11       Impact factor: 2.931

5.  Clinical characteristics and outcomes of rural patients with ESRD in Guangxi, China: one dialysis center experience.

Authors:  Wenxin Zhang; Zhifeng Gong; Xiaomei Peng; Sheng Tang; Ming Bi; Wentan Huang
Journal:  Int Urol Nephrol       Date:  2009-07-14       Impact factor: 2.370

Review 6.  Evolving cardiovascular disease prevalence, mortality, risk factors, and the metabolic syndrome in China.

Authors:  Yixiu Zheng; Richard Stein; Tak Kwan; Christine Yu; Joanne Kwan; Shao-liang Chen; Dayi Hu
Journal:  Clin Cardiol       Date:  2009-09       Impact factor: 2.882

7.  Preface to the First Issue, JCDR.

Authors:  Zhou Peng
Journal:  J Cardiovasc Dis Res       Date:  2010-01

8.  Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population.

Authors:  Zhen Yang; Xuanchun Wang; Jie Wen; Zi Ye; Qin Li; Min He; Bin Lu; Charlotte Ling; Songhua Wu; Renming Hu
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

9.  Relation between metabolic syndrome and body compositions among Chinese adolescents and adults from a large-scale population survey.

Authors:  Tao Xu; Junting Liu; Junxiu Liu; Guangjin Zhu; Shaomei Han
Journal:  BMC Public Health       Date:  2017-04-20       Impact factor: 3.295

10.  Time trend of cardiometabolic risk factors over a 10-year period in the office-working population in China.

Authors:  Yang Cheng; Hongli Yin; Zhixiang Shen; Liubao Gu; Hui Zheng; Donghua Yin; Gang Yin; Shanping Ying; Xiaohong Li; Hui Dai; Lvkun Zhao; Chong Shen
Journal:  BMJ Open       Date:  2019-06-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.